CUERVO:BMVBecle, S.A.B. de C.V. Analysis
Data as of 2026-03-17 - not real-time
MX$15.09
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Becle, S.A.B. de C.V. (CUERVO) trades at MXN 15.09, well below its 20‑day (MXN 17.41), 50‑day (MXN 19.22) and 200‑day (MXN 21.20) moving averages, indicating a bearish technical backdrop. RSI at 20.3 signals oversold conditions, while the MACD remains bearish, suggesting limited short‑term upside but a potential for a technical rebound. The company’s fundamentals show a low PE of 6.3, PB of 0.77 and a dividend yield of 2.63% with a modest 16% payout, underscoring a defensible income stream. However, Q4 FY2025 revealed a 14% YoY decline in net sales (8.4% FX‑adjusted), and revenue growth is negative at –14.1%, highlighting near‑term earnings pressure. Despite the sales dip, margins remain strong (gross 56%, operating 21%, profit 20%) and free cash flow is robust at MXN 6.6 bn, supporting dividend sustainability. The balance sheet carries MXN 20.8 bn of debt against MXN 11.1 bn of cash, yielding a high debt‑to‑equity ratio, but liquidity is adequate. A DCF fair value of MXN 22.29 implies ~67% upside, and analyst consensus (11 analysts) rates the stock as a Buy with a median target of MXN 27.
Overall, the stock appears significantly undervalued with solid cash generation and a stable dividend, yet faces short‑term revenue headwinds and elevated price volatility.
Overall, the stock appears significantly undervalued with solid cash generation and a stable dividend, yet faces short‑term revenue headwinds and elevated price volatility.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below key moving averages and bearish MACD
- Oversold RSI suggesting limited upside
- Recent sales decline impacting earnings
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Substantial valuation gap to DCF fair value
- Strong cash flow and sustainable dividend
- Analyst consensus and upside potential
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Resilient brand portfolio in consumer defensive sector
- Stable profitability and low beta indicating defensive characteristics
- Long‑term upside from undervaluation and dividend yield
Key Metrics & Analysis
Financial Health
Revenue Growth-14.10%
Profit Margin20.07%
P/E Ratio6.3
ROE12.63%
ROA5.53%
Debt/Equity29.63
P/B Ratio0.8
Op. Cash FlowMX$8.2B
Free Cash FlowMX$6.6B
Technical Analysis
TrendBearish
RSI20.3
SupportMX$0.00
ResistanceMX$19.39
MA 20MX$17.41
MA 50MX$19.22
MA 200MX$21.20
MACDBearish
VolumeIncreasing
Fear & Greed Index80.82
Valuation
Fair ValueMX$22.29
Target PriceMX$25.31
Upside/Downside67.72%
GradeUndervalued
TypeValue
Dividend Yield2.63%
Risk Assessment
Beta0.19
Volatility34.05%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.